A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation

Emily C Milam; Kathryn J Martires; Kristen I Lo Sicco; David J Araten; Andrew G Franks Jr

doi:10.1016/j.jdcr.2019.01.003

A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation

JAAD Case Rep. 2019 Feb 12;5(3):228-230. doi: 10.1016/j.jdcr.2019.01.003. eCollection 2019 Mar.

Authors

Emily C Milam¹, Kathryn J Martires¹, Kristen I Lo Sicco¹, David J Araten², Andrew G Franks Jr^{1

3}

Affiliations

¹ The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
² Department of Medicine, Division of Hematology, New York University School of Medicine, New York, New York.
³ Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, New York.

No abstract available

Keywords: CyBorD, cyclophosphamide, bortezomib, and dexamethasone; POEMS syndrome; POEMS, polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes; SDH, spontaneous subdural hemorrhage; VEGF, vascular endothelial growth factor; and skin changes; autologous stem cell transplantation; chemotherapy; endocrinopathy; monoclonal gammopathy; polyneuropathy organomegaly.

Publication types

Case Reports